Qiwu Zhao

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Nlrp Inflammasome

Top Venues

Journal of clinical medicine

British journal of cancer

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Qiwu Zhao, Haoran Feng, Zheyu Yang, Juyong Liang, Zhijian Jin, Lingxie Chen, Ling Zhan, Ming Xuan, Jiqi Yan, Jie Kuang, Xi Cheng, Ren Zhao, Weihua Qiu
The central role of a two-way positive feedback pathway in molecular targeted therapies-mediated pyroptosis in anaplastic thyroid cancer. Clinical and translational medicine 12 (2) (2022)
Wenqing Jia, Zhuoran Liu, Ling Zhan, Qiwu Zhao, Weihua Qiu, Jie Kuang
Editorial: Apatinib and Anlotinib in the Treatment of Radioactive Iodine Refractory and Highly Invasive Thyroid Carcinoma. Journal of clinical medicine 11 (21) (2022)
Juyong Liang, Zhijian Jin, Jie Kuang, Haoran Feng, Qiwu Zhao, Zheyu Yang, Ling Zhan, Baiyong Shen, Jiqi Yan, Wei Cai, Xi Cheng, Weihua Qiu
The role of anlotinib-mediated EGFR blockade in a positive feedback loop of CXCL11-EGF-EGFR signalling in anaplastic thyroid cancer angiogenesis. British journal of cancer 125 (3) (2021)
Haoran Feng, Zhijian Jin, Juyong Liang, Qiwu Zhao, Ling Zhan, Zheyu Yang, Jiqi Yan, Jie Kuang, Xi Cheng, Weihua Qiu
FOXK2 transcriptionally activating VEGFA induces apatinib resistance in anaplastic thyroid cancer through VEGFA/VEGFR1 pathway. Oncogene 40 (42) (2021)
Zhijian Jin, Haoran Feng, Juyong Liang, Xiaoqian Jing, Qiwu Zhao, Ling Zhan, Baiyong Shen, Xi Cheng, Liping Su, Weihua Qiu
FGFR3△7-9 promotes tumor progression via the phosphorylation and destabilization of ten-eleven translocation-2 in human hepatocellular carcinoma. Cell death & disease 11 (10) (2020)